• 1
    Fouchard, N., Flageul, B., Bagot, M., Avril, M.-F., Hermine, O., Sigaux, F., Merle-Beral, H., Troussard, X., Delfraissy, J.-F., de The, G., Gessain, A. (1995) Lack of evidence of HTLV-I/II infection in T-CD8 malignant or reactive lymphoproliferative disorders in France: a serological and/or molecular study of 169 cases. Leukemia, 9, 2087 2092.
  • 2
    Kojima, K., Sawada, T., Yasukawa, M., Matsuo, Y., Yakushijin, Y., Narumi, H., Azuma, T., Takimoto, H., Hara, M. (1998) Deleted HTLV provirus in peripheral blood cells of a patient with T-cell prolymphocytic leukaemia. British Journal of Haematology, 100, 567 570.
  • 3
    Matutes, E., Brito-Babapulle, V., Swansbury, J., Ellis, J., Morilla, R., Dearden, C., Sempere, A., Catvosky, D. (1991) Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood, 78, 3269 3274.
  • 4
    Pandolfi, F., Manzari, V., de Rossi, G., Semenzato, G., Lauria, F., Liso, V., Ranucci, A., Pizzolo, G., Barillari, G., Aiuti, F. (1985) T-helper phenotype chronic lymphocytic leukaemia and ‘adult T-cell leukaemia’ in Italy. Lancet, ii, 633 636.
  • 5
    Pawson, R., Schulz, T.F., Weiss, R.A., Matutes, E., Catovsky, D. (1997) The human T-cell lymphotropic viruses types I/II are not involved in T-prolymphocytic leukemia and large granular lymphocytic leukemia. Leukemia, 11, 1305 1311.
  • 6
    Pombo de Oliveira, M.S., Matutes, E.M., Schulz, T.F., Carvalho, S.M., Noronha, H., Reaves, J.D., Loureiro, P., Machado, C., Catovsky, D. (1995) T-cell malignancies in Brazil: clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. International Journal of Cancer, 60, 823 827.